Quote this publication Share Print

KETUM

-
Opinions on drugs - Posted on May 21 2013

Reason for request

Renewal of inclusion

-


Clinical Benefit

Insufficient

Insufficient for reimbursement by National Health Insurance in all the Marketing Authorisation indications (superficial tendinitis, benign trauma, small-joint osteoarthritis, low back pain and postsclerotherapeutic phlebitis).


Clinical Added Value

Not applicable

Not applicable